scholarly journals Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Marco Gerling ◽  
Nikè V. J. A. Büller ◽  
Leonard M. Kirn ◽  
Simon Joost ◽  
Oliver Frings ◽  
...  

Abstract A role for Hedgehog (Hh) signalling in the development of colorectal cancer (CRC) has been proposed. In CRC and other solid tumours, Hh ligands are upregulated; however, a specific Hh antagonist provided no benefit in a clinical trial. Here we use Hh reporter mice to show that downstream Hh activity is unexpectedly diminished in a mouse model of colitis-associated colon cancer, and that downstream Hh signalling is restricted to the stroma. Functionally, stroma-specific Hh activation in mice markedly reduces the tumour load and blocks progression of advanced neoplasms, partly via the modulation of BMP signalling and restriction of the colonic stem cell signature. By contrast, attenuated Hh signalling accelerates colonic tumourigenesis. In human CRC, downstream Hh activity is similarly reduced and canonical Hh signalling remains predominantly paracrine. Our results suggest that diminished downstream Hh signalling enhances CRC development, and that stromal Hh activation can act as a colonic tumour suppressor.

2015 ◽  
Vol 46 (4) ◽  
pp. 1582-1588 ◽  
Author(s):  
FEIFENG JING ◽  
HUN JIN KIM ◽  
CHANG HYUN KIM ◽  
YOUNG JIN KIM ◽  
JAE HYUK LEE ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 4124-4124
Author(s):  
T. Yeung ◽  
J. Wilding ◽  
W. Bodmer

4124 Background: Cancer stem cells are defined as cells within a tumour that are able to self-renew and differentiate into all cell lineages within that tumour. With our extensive panel of colorectal cell lines, our aims are: 1) To characterise and isolate cancer stem cells based on stem cell markers, morphological appearances and the ability to form multiple lineages; 2) To understand how cancer stem cells drive tumour growth and progression. Methods: 1) Fluorescent Activated Cell Sorting (FACS); 2) In vitro soft agar clonogenic and Matrigel differentiation assays; 3) In vivo tumourigenic NOD/SCID mice assay; 4) Confocal immunofluorescence imaging. Results: 1) A subpopulation of cells can differentiate into crypt-like megacolonies, retaining the ability to self-renew and differentiate. SW1222 cell line forms heterogeneous colonies when single cells are plated in Matrigel. Megacolonies can both self-renew and form terminally differentiated small colonies, whereas small colonies cannot form megacolonies. Megacolonies develop crypt-like structures and increase their expression of differentiation markers (CDX-1, CK-20) over time. Experiments are currently under way to confirm that cells from megacolonies are able to initiate tumours in NOD/SCID mice. Some cell lines retain the ability to differentiate into both neuroendocrine and epithelial lineages. 2) CD44+CD24+ enriches for the cancer stem cell population. Colorectal cancer cell lines HCT116, HT29, LS180, LS174T and SW1222 express both CD44 and CD24. The CD44+CD24+ subpopulation is the most clonogenic. In SW1222, CD44+CD24+ cells enrich for megacolonies and can reform all four CD44/CD24 subpopulations. 3) Hypoxia reduces differentiation, increases stem-like phenotype and enhances clonogenicity. Hypoxia increases the proportion of undifferentiated colorectal cancer cells when plated on Matrigel and increases clonogenicity. Conclusions: 1) Colorectal cancer cell lines contain subpopulations of cells that have the ability to self-renew, differentiate and drive tumour growth, and may be characterised by their cell surface markers and colony morphology. 2) CD44+CD24+ can be used as markers for colorectal cancer stem cells. 3) Hypoxia increases the stem-like phenotype of cancer cells, reduces differentiation and increases clonogenicity. No significant financial relationships to disclose.


2013 ◽  
Vol 144 (5) ◽  
pp. S-463
Author(s):  
Maria Ausiliatrice Puglisi ◽  
Valentina Tesori ◽  
Achille Cittadini ◽  
Giovanni Gasbarrini ◽  
Giovambattista Pani ◽  
...  

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Marco Gerling ◽  
Nikè V.J.A. Büller ◽  
Leonard M Kirn ◽  
Simon Joost ◽  
Oliver Frings ◽  
...  

Author(s):  
Vasudevan Sekar

Colorectal cancer the third-leading cause of cancer mortality Worldwide; it's a well characterised model at molecular level among various cancera. Chronic ulcerative colitis is one of the causes of colorectal cancer. Recent cancer research focuses on tumor-initiating cells which are the cause of tumor initiation, invasions, drug-resistant, recurrence, and metastasis. Emerging research findings support the presence of colon cancer stem cells in sporadic colorectal cancer and in colitis-associated colorectal cancer. Colitis-associated cancer cells exhibit increased colon cancer stem cell marker expression along with activated developmental signaling pathways. Also, emerging reports exhibit that inhibition stem cell markers in chronic ulcerative colitis cells impedes progression of cancer in genetically engineered animal models and primary samples. This chapter deals of colitis-cancer transition, microenvironment of colitis-associated colorectal cancer, and articulates that cancer stem cells are ideal targets for colorectal cancer.


2018 ◽  
Vol 115 (22) ◽  
pp. E5066-E5075 ◽  
Author(s):  
Changlong Liu ◽  
Carolyn E. Banister ◽  
Charles C. Weige ◽  
Diego Altomare ◽  
Joseph H. Richardson ◽  
...  

PRDM1 is a tumor suppressor that plays an important role in B and T cell lymphomas. Our previous studies demonstrated that PRDM1β is a p53-response gene in human colorectal cancer cells. However, the function of PRDM1β in colorectal cancer cells and colon tumor organoids is not clear. Here we show that PRDM1β is a p53-response gene in human colon organoids and that low PRDM1 expression predicts poor survival in colon cancer patients. We engineered PRDM1 knockouts and overexpression clones in RKO cells and characterized the PRDM1-dependent transcript landscapes, revealing that both the α and β transcript isoforms repress MYC-response genes and stem cell-related genes. Finally, we show that forced expression of PRDM1 in human colon cancer organoids prevents the formation and growth of colon tumor organoids in vitro. These results suggest that p53 may exert tumor-suppressive effects in part through a PRDM1-dependent silencing of stem cell genes, depleting the size of the normal intestinal stem cell compartment in response to DNA damage.


2007 ◽  
Vol 5 (9) ◽  
pp. 940
Author(s):  
_ _

In 2007, an estimated 41,420 new cases of rectal cancer will occur in the United States (23,840 cases in men; 17,580 cases in women). The guidelines for rectal cancer overlap considerably with those for colon cancer, and the panel unanimously endorses patient participation in a clinical trial over standard or accepted therapy in both. This is especially true for cases of advanced disease and for patients with locally aggressive colorectal cancer who are receiving combined modality treatment. The latest updates of the NCCN Anal Carcinoma Clinical Practice Guidelines in Oncology are available online at www.nccn.org. For the most recent version of the guidelines, please visit NCCN.org


Sign in / Sign up

Export Citation Format

Share Document